Good prospects for the future.
You can read about our progress and milestones, about our expansions and our experts, about our engagement and exchanges, in brief: about everything that motivates us.
Heidelberg, April 4, 2023
New data just published online in the prestigious journal JAMA Neurology has demonstrated the safety and efficacy of EASEE®, the world's first minimally invasive brain pacemaker, i […]
Read moreHeidelberg, February 1, 2023
Successful participation in innovation competition / Ranga Yogeshwar congratulates the company in June.
Read moreHeidelberg, September 23, 2022
After seven years of development work, Precisis GmbH, headquartered in Heidelberg, has received the CE certification for its minimally invasive brain pacemaker EASEE®.
Read moreHeidelberg, April 29, 2022
Prof. Andreas Schulze-Bonhage, MD, Head of the Epilepsy Center at the University Hospital Freiburg, who is responsible for the multi-center study on the efficacy of EASEE®, present […]
Read moreHeidelberg, February 21, 2022
Heidelberg-based Precisis GmbH has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its EASEE® brain stimulator. FDA’s breakthrough dev […]
Read moreHeidelberg, October 21, 2021
Today, Precisis GmbH, based in Heidelberg, announced that it has successfully concluded a funding round of €20 million with Cochlear Limited. Precisis is a medical technology compa […]
Read more
